Rep. Chris Smith (R-NJ), Co-Chair of the Congressional Pro-Life Caucus, issued the below statement following the Supreme Court’s ruling in Danco Laboratories v. Louisiana, which reversed the Fifth Circuit Court of Appeals’ decision to pause the Biden Administration’s dangerous mail-order abortion drug policy. Both Danco Laboratories and GenBioPro, two manufacturers of mifepristone, submitted the applications for stay:

                “The Supreme Court’s ruling today is deeply disheartening. But it’s not over – the fight to protect women and children from baby poison (the abortion pill) will continue.

                “The Fifth Circuit Court was right to halt this ill-advised policy while litigation continues in the lower courts, as mifepristone is extremely dangerous to both mother and child. Nearly 11% of women—more than one in ten—who take this dangerous drug experience serious, adverse events within 45 days, including sepsis, hemorrhaging, and/or infection.

                “The severe and sustained harms that mifepristone poses to babies and their mothers cannot be ignored. The named and nameless victims of this chemical abortion drug deserve relief and protection.”

###